Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Lancet. Gastroenterology & Hepatology|September 11, 2021
Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan AfricaC Wendy Spearman, Abdelmounem Abdo, Aggrey Ambali, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 21, 2005
Quantitative analysis of plasma TP53 249Ser-mutated DNA by electrospray ionization mass spectrometryMatilde E Lleonart, Gregory D Kirk, Stephanie Villar, et al.
Carcinogenesis|July 5, 2012
TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The GambiaDoriane A Gouas, Stphanie Villar, Sandra Ortiz-Cuaran, et al.
Journal of Viral Hepatitis|October 31, 2009
Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West AfricaM E Mendy, T Welzel, O A Lesi, et al.
HIV/AIDS (Auckland, N.Z.)|April 18, 2014
Potential drug-drug interactions in HIV-infected children on antiretroviral therapy in Lagos, NigeriaKazeem A Oshikoya, Ibrahim A Oreagba, Saheed Lawal, et al.
International Journal of Cancer|May 8, 2014
Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinomaAndre Nogueira da Costa, Amelie Plymoth, Daniela Santos-Silva, et al.
Plos One|March 6, 2023
Hepatocellular carcinoma presentation and prognosis among Nigerian adults with and without HIVPantong M Davwar, Edith Okeke, Mary Duguru, et al.
The Lancet. Gastroenterology & Hepatology|July 10, 2022
Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan AfricaC Wendy Spearman, Geoffrey Dusheiko, Eduard Jonas, et al.
Hepatology International|December 20, 2024
Cell-free DNA methylation-based inflammation score as a marker for hepatocellular carcinoma among people living with HIVKyeezu Kim, Yinan Zheng, Brian T Joyce, et al.
Pageof 6